Altratech has discovered and patented a fundamentally novel process to detect and quantify DNA, RNA, Antibody, and Antigen molecular targets. UbiHealth replaces the need for time consuming ‘biological amplification’ required for optical read-outs, with almost instant ‘electronic signal amplification’ and a digital read-out.